TSVT — 2Seventy Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for 2Seventy Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS/A	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	—	265	266	217	175
Net Total Accounts Receivable
Net Total Receivables	10.7	17	21	13.4	7.78
Prepaid Expenses
Total Current Assets	25.1	292	301	238	187
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	260	310	297	278	238
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	313	760	657	565	480
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	75.9	98.4	79.8	59.8	40.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	238	400	346	310	269
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	74.6	360	310	255	211
Total Liabilities & Shareholders' Equity	313	760	657	565	480
Total Common Shares Outstanding